Literature DB >> 7875320

Molecular cloning of a novel C or gamma type chemokine, SCM-1.

T Yoshida1, T Imai, M Kakizaki, M Nishimura, O Yoshie.   

Abstract

From human PBMC stimulated with PHA, we have isolated cDNA clones encoding a novel cytokine named SCM-1, which is significantly related to the CC and the CXC chemokines but has only the 2nd and the 4th of the four cysteines conserved in these proteins. Its gene is also distinctly mapped to human chromosome 1. SCM-1 is strongly induced in human PBMC and Jurkat T cells by PHA stimulation. Among various human tissues, SCM-1 is expressed most strongly in spleen. SCM-1 is found to be 60.5% identical to lymphotactin, a recently described murine lymphocyte-specific chemokine, which also retains only two cysteines. SCM-1 and lymphotactin may thus represent the human and murine prototypes of a novel C or gamma type chemokine family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875320     DOI: 10.1016/0014-5793(95)00093-o

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  Bioinformatics and cancer research: building bridges for translational research.

Authors:  Gonzalo Gómez-López; Alfonso Valencia
Journal:  Clin Transl Oncol       Date:  2008-02       Impact factor: 3.405

2.  Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis.

Authors:  A R Glabinski; M Tani; R M Strieter; V K Tuohy; R M Ransohoff
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease.

Authors:  P Middel; P Thelen; S Blaschke; F Polzien; K Reich; V Blaschke; A Wrede; K M Hummel; B Gunawan; H J Radzun
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure.

Authors:  M R MacDonald; M W Burney; S B Resnick; I V Virgin HW
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  The success (or not) of HUGO nomenclature.

Authors:  Javier Tamames; Alfonso Valencia
Journal:  Genome Biol       Date:  2006-05-15       Impact factor: 13.583

6.  Rat macrophage inflammatory protein-1alpha, a CC chemokine, acts as a neutrophil chemoattractant in vitro and in vivo.

Authors:  K Takano; M Al-Mokdad; F Shibata; H Tsuchiya; H Nakagawa
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

7.  MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.

Authors:  Brigitte G Dorner; Alexander Scheffold; Michael S Rolph; Martin B Huser; Stefan H E Kaufmann; Andreas Radbruch; Inge E A Flesch; Richard A Kroczek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Expression of lymphotactin mRNA in experimental crescentic glomerulonephritis.

Authors:  Y Natori; Z L Ou; Y Yamamoto-Shuda; Y Natori
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.

Authors:  Jamie C Fox; Takashi Nakayama; Robert C Tyler; Tara L Sander; Osamu Yoshie; Brian F Volkman
Journal:  Cytokine       Date:  2014-12-11       Impact factor: 3.861

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.